Serine protease inhibitors decrease metastasis in prostate, breast, and ovarian cancers
Targeted therapies for prostate, breast, and ovarian cancers are based on their activity against primary tumors rather than their anti‐metastatic activity. Consequently, there is an urgent need for new agents targeting the metastatic process. Emerging evidence correlates in vitro and in vivo cancer...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2023-11-01
|
| coleção: | Molecular Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/1878-0261.13513 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|